Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer

Oral Oncology

Volumn 46, Issue 4, 2010, Pages 249-254

  Chen, Min Chi ^a   Huang, Wei Chao ^b,c   Chan, Chunghuang Hubert ^b,d   Chen, Ping Tsung ^b,c   Lee, Kuan Der ^b,c,d  

^a Biostatistics Consulting Center   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Esophagus; Head and neck cancer; Lung; Second cancer; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; SECOND CANCER;

ADOLESCENT; ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CHILD; ESOPHAGEAL NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 77949569555     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.01.002     Document Type: Article

References (22)

1. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 1 (1999) 33-64
2. Licciardello J.T., Spitz M.R., and Hong W.K. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 17 3 (1989) 467-476
3. Rennemo E., Zatterstrom U., and Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2063 cases. Laryngoscope 118 8 (2008) 1350-1356
4. Schwartz L.H., Ozsahin M., Zhang G.N., Touboul E., De Vataire F., Andolenko P., et al. Synchronous and metachronous head and neck carcinomas. Cancer 74 7 (1994) 1933-1938
5. Tsou Y.A., Hua C.H., Tseng H.C., Lin M.H., and Tsai M.H. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol 127 6 (2007) 651-657
6. Hong W.K., Lippman S.M., Itri L.M., Karp D.D., Lee J.S., Byers R.M., et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323 12 (1990) 795-801
7. Chen M.C., Feng I.J., Lu C.H., Chen C.C., Lin J.T., Huang S.H., et al. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003). Ann Oncol 19 6 (2008) 1180-1186
8. Tepperman B.S., and Fitzpatrick P.J. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 2 8246 (1981) 547-549
9. Chuang S.C., Scelo G., Tonita J.M., Tamaro S., Jonasson J.G., Kliewer E.V., et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 123 10 (2008) 2390-2396
10. Slee V.N. The international classification of diseases: ninth revision (ICD-9). Ann Intern Med 88 3 (1978) 424-426
11. Parkin D.M., and Muir C.S. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 120 (1992) 45-173
12. Cox D.R. Regression models and life tables. J Roy Stat Soc Ser B 34 (1972) 187-220
13. Cox D.R. Partial likelihood. Biometrika 62 (1975) 269-276
14. Lee K.D., Lu C.H., Chen P.T., Chan C.H., Lin J.T., Huang C.E., et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer 9 (2009) 373-383
15. D′Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papilloma virus and oropharyngeal cancer. N Engl J Med 356 19 (2007) 1944-1956
16. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papilloma virus and a subset of head and neck cancers. J Natl Cancer Inst 92 9 (2000) 709-720
17. Chien Y.C., Chen J.Y., Liu M.Y., Yang H.I., Hsu M.M., Chen C.J., et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345 26 (2001) 1877-1882
18. Cooper J.S., Pajak T.F., Rubin P., Tupchong L., Brady L.W., Leibel S.A., et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17 3 (1989) 449-456
19. Day G.L., Blot W.J., Shore R.E., Schoenberg J.B., Kohler B.A., Greenberg R.S., et al. Second cancers following oral and pharyngeal cancer: patients' characteristics and survival patterns. Eur J Cancer B Oral Oncol 30B 6 (1994) 381-386
20. Rafferty M.A., and O'Dwyer T.P. Secondary primary malignancies in head and neck squamous cell carcinoma. J Laryngol Otol 115 12 (2001) 988-991
21. Lee K.D., Chen S.C., Chan C.H., Lu C.H., Chen C.C., Lin J.T., et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev 17 10 (2008) 2647-2655
22. Schaapveld M., Visser O., Louwman M.J., de Vries E.G., Willemse P.H., Otter R., et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 26 8 (2008) 1239-1246